Human movement company Scientific Analytics Inc reported on Wednesday the receipt of the US FDA's 510K medical device designation for its computer-vision-powered motion health analysis technology, DARI Health.
According to the company, its markerless DARI Motion computer vision and biomechanical analysis technology has been refined by more than 425bn data points of human motion gathered across applications in wellness, military, elite athletics and healthcare. It helps people and organisations to improve performance, avoid injury and reduce unnecessary costs.
Scientific Analytics has also formed a strategic collaboration with Hospital for Special Surgery (HSS), the world's largest academic musculoskeletal health company.
The newly formed partnership will integrate leading knowledge and technology with the aim of setting new standards for full-body, dynamic motion analysis at population scale. It will provide the first medical device that will arm clinicians with an FDA-cleared, accurate and reliable solution that easily and seamlessly captures clinically-relevant human movement data at the point of care.
Through the partnership, the companies aim to create a new standard in data-driven, value-based musculoskeletal health while objectively documenting outcomes and delivering an engaging patient experience.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions